Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cardoe N. A 2-year study of the efficacy and tolerability of prenylamine in the treatment of angina pectoris. Postgrad Med J. 1970 Dec;46(542):708–712. doi: 10.1136/pgmj.46.542.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hodge R. L. Investigation of a possible beta-blocking action of prenylamine in man. Aust J Exp Biol Med Sci. 1969 Oct;47(5):651–652. doi: 10.1038/icb.1969.162. [DOI] [PubMed] [Google Scholar]
- Matthews M. B., Turck W. P. Drugs in the management of angina pectoris. Practitioner. 1969 Feb;202(208):230–237. [PubMed] [Google Scholar]
- Nielsen K. C., Owman C. Differential amine depletion from cardiac adrenergic nerves by segontin. Experientia. 1967 Mar 15;23(3):203–204. doi: 10.1007/BF02136287. [DOI] [PubMed] [Google Scholar]
- Obianwu H. O. The effect of prenylamine (segontin) on the amine levels of brain, heart and adrenal medulla in rats. Acta Pharmacol Toxicol (Copenh) 1965;23(4):383–390. doi: 10.1111/j.1600-0773.1965.tb00362.x. [DOI] [PubMed] [Google Scholar]
- Stoker J. B. Effect of prenylamine in angina pectoris. Br J Clin Pract. 1968 Sep;22(9):384–385. [PubMed] [Google Scholar]
- Winsor R., Bleifer K., Cole S., Goldman I. R., Karpman H., Oblath R., Stone S. A double-blind, double cross-over trial of prenylamine in angina pectoris. Am Heart J. 1971 Jul;82(1):43–54. doi: 10.1016/0002-8703(71)90160-8. [DOI] [PubMed] [Google Scholar]